Sigurdur O. Olafsson, PRES.-ACTAVIS PHARMA at Actavis plc (ACT), sold 25,000 shares at $159.87 ($4.0M) on 2013-11-11, disclosed to the SEC on 2013-11-13.
Open-market sale of $4.0M ACT by PRES.-ACTAVIS PHARMA. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |